It is currently Fri Feb 27, 2015 1:26 pm

News News of Copaxone

Site map of Copaxone » Forum : Copaxone

A board to discuss the Multiple Sclerosis modifying drug Copaxone

US Supreme Court sides with Teva in patent dispute....

US Supreme Court sides with Teva in patent dispute over multiple sclerosis drug

The Supreme Court has sided with Teva Pharmaceutical Industries Ltd. in the company's high-profile patent dispute with rival firms over the top-selling multiple sclerosis drug.

The justices ruled Tuesday that a federal appeals court wrongly overturned five of Teva's patents for the drug Copaxone. The decision allows the Israel-based company to keep its exclusive rights to the drug until September 2015...... Read ...
Read more : US Supreme Court sides with Teva in patent dispute.... | Views : 321 | Replies : 0


First injection (manually) ever all by myself. Yeah i did i!

The nurse came over yesterday afternoon and i injected manually in my arm with the left hand (I'm right handed). Yeah i did it! I was very very very nervous but glad that first one is over with. It's definitely overwhelming because how do you know exactly where to put it and what the heck you are doing, depth, pinch, let go, ugh there's a lot to remember. Can you do the shot and not ...
Read more : First injection (manually) ever all by myself. Yeah i did i! | Views : 252 | Replies : 1


Going through customs with copaxone

Hi- I am getting ready for a trip to Costa RIca in a couple weeks. I have a copy of my prescription for security on the US side of things, but I am worried that Costa Rica customs may not be so understanding about someone bringing filled syringes into the country.
Has anyone done this? Any advice?
Thank you!

PS I'm on Copaxone 40, traveling for 6 days so I'll only need to take a ...
Read more : Going through customs with copaxone | Views : 444 | Replies : 5


3x weekly Copaxone dosing receives pelminary positive......

Thrice-weekly Copaxone dosing receives pelminary positive outcome in Europe

Teva Pharmaceutical Industries Ltd. announced that its thrice-weekly Copaxone® (glatiramer acetate) 40mg/ml treatment for relapsing-remitting multiple sclerosis (RRMS) has received positive results in a decentralized procedure. The favourable outcome proceeds a Positive Assessment Report from the United Kingdom, the Reference Member State’s Medicines and Healthcare Products Regulatory Agency (MHRA), and all Concerned Member States (CMS) in Europe that had participated in the procedure. The company is ...
Read more : 3x weekly Copaxone dosing receives pelminary positive...... | Views : 568 | Replies : 0


Copaxone moves toward Japanese regulatory approval

Teva Pharmaceutical Industries Ltd. multiple sclerosis treatment Copaxone is progressing toward regulatory approval in Japan. At the end of 2013, Teva reported a development and marketing agreement with Japan's Takeda Pharmaceutical Co. Ltd. for the Japanese market.

At the time, Teva said that regulatory approval was expected to be received in less than a year. However, nearly a year has passed and no approval has been received......... Read More - http://www.ms-uk.org/copaxone
Read more : Copaxone moves toward Japanese regulatory approval | Views : 441 | Replies : 0


i switched meds and now i have many boxes of copaxone

does anyone want them? i have one box that expires at the end of next month and the rest are all in 2015. i'm in the bay area and if you live somewhat close or are local that would be ideal, but mostly i just want someone to make good use of them. PM for more details.
Read more : i switched meds and now i have many boxes of copaxone | Views : 614 | Replies : 2


Copaxone therapy remodels the composition of B-Cells

The Effect of Glatiramer Acetate Therapy on Functional Properties of B Cells From Patients With Relapsing-Remitting Multiple Sclerosis.

Sara J. Ireland, BA; Alyssa A. Guzman, BS; Dina E. O’Brien, BS; Samuel Hughes; Benjamin Greenberg, MD; Angela Flores, MD; Donna Graves, MD; Gina Remington, BSN, RN; Elliot M. Frohman, MD, PhD; Laurie S. Davis, PhD; Nancy L. Monson, PhD.

Abstract

Importance: This study describes what is, to our knowledge, the previously unknown effect of glatiramer acetate ...
Read more : Copaxone therapy remodels the composition of B-Cells | Views : 461 | Replies : 0


Skipping a Shot Once a Week

My insurance is refusing to pay for the new dosage of Copaxone of 40 mg. 3xwk. Since my skin is a mess (and I rotate!) and I am running out of shot sites, I have been skipping one shot a week for about three months. It adds up to the same amount of medicine I would be getting if I were able to get the new dosage. Now I am in relapse, but I don't ...
Read more : Skipping a Shot Once a Week | Views : 601 | Replies : 5


First generic medication for MS developed

New study finds a generic version of Copaxone to be just as effective, safe.

A new study on the first generic medication for Multiple Sclerosis is showing promising results when compared to the widely-used name brand medication, Copaxone...... Read More - http://www.ms-uk.org/copaxone
Read more : First generic medication for MS developed | Views : 467 | Replies : 0


Teva’s Copaxone patent problems continue

Teva Pharmaceuticals Industries Ltd is in trouble again for its multiple sclerosis (MS) injectable drug-Copaxone, as other drug manufacturers seek to launch their own generic versions of the drug. Teva has been fighting patent battles to ward off other pharmaceutical companies from making generic copies of Copaxone.

Copaxone makes up one-fifth of the company’s sales, but it is expected to lose 50% of its revenues by 2016, after its generic copies are launched. To deal ...
Read more : Teva’s Copaxone patent problems continue | Views : 643 | Replies : 1


 

Login  •  Register


Statistics

Total posts 223870 • Total topics 23316 • Total members 14752


Contact us | Terms of Service